v3.26.1
Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
Number of subordinate voting shares [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Balance - December 31, 2025 at Dec. 31, 2024 $ 52,365,328 $ (125,930) $ (43,293,760) $ 1,629,981 $ 10,575,619
Beginning balance, shares at Dec. 31, 2024 222,446,113          
Exercise of stock options   16,038 16,038
Exercise of stock options, shares 50,000          
Settlement of July Convertible Debentures   2,468,534 2,468,534
Settlement of December Convertible Debentures, shares 4,505,625          
Settlement of restricted share units  
Settlement of restricted share units, shares 291,700          
Share-based compensation expense   1,435,910 1,435,910
Currency translation adjustment   7,832 7,832
Net income   598,782 144,088 742,870
Balance - March 31, 2026 at Mar. 31, 2025 56,285,810 (118,098) (42,694,978) 1,774,069 15,246,803
Ending balance, shares at Mar. 31, 2025 227,293,438          
Balance - December 31, 2025 at Dec. 31, 2025 62,589,075 (121,906) (41,563,955) 3,015,133 23,918,347
Beginning balance, shares at Dec. 31, 2025 249,738,980          
Sale of non-controlling interest in GRMA   2,985,000 2,985,000
Exercise of stock options   21,839 21,839
Exercise of stock options, shares 200,000          
Distributions to non-controlling interests in subsidiaries   (85,156) (85,156)
Reclassification of warrants   (1,539,665) (1,539,665)
Share-based compensation expense   154,994 154,994
Net income   (2,702,217) 488,826 (2,213,391)
Balance - March 31, 2026 at Mar. 31, 2026 $ 61,226,243 $ (121,906) $ (44,266,172) $ 6,403,803 $ 23,241,968
Ending balance, shares at Mar. 31, 2026 249,938,980